A Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 with Gembitabine as First-Line Therapy in Patients with Metastic Pancreatic Adenocarcinoma, EUDRACT 2009-018240-23

  • Palmer, Daniel (Principal Investigator)

Project Details

Short titleA Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 with Gembitabine as First-Line Therapy in Patients with Metastic Pancreatic Adenocarcinoma, EUDRACT 2009-018240-23
StatusFinished
Effective start/end date1/11/10 → 31/10/12

Funding

  • Queen Elizabeth Hospital Birmingham